-
Access barriers to the dedicated emergency contraceptive pill (ECP) Plan B are set to be lifted. A federal judge has instructed the Food and Drug Administration (FDA) to make Plan B available to 17-year-olds and ordered the agency to review whether to make the ECP available to females 17 and under without prescription.
-
Today, women account for more than one-quarter of all new HIV/AIDS diagnoses in the United States, according to the Centers for Disease Control and Prevention.
-
Reproductive health advocates are throwing their support behind the Obama administration's move to rescind a controversial "conscience" rule that would expand the right of health care personnel and institutions to refuse to provide or assist in the provision of services on moral or religious grounds.
-
-
Research findings presented at a February 2009 international conference indicate that an investigational gel known as PRO 2000 (Indevus Pharmaceuticals; Lexington, MA) proved about 30% effective in preventing HIV infection in women.
-
The next patient in your exam room is a 17-year-old female who uses the contraceptive injection depot medroxyprogesterone acetate (DMPA) for birth control.
-
Your next patient is an adolescent female who has requested immunization with the vaccine for human papillomavirus (HPV). When she asks specifically about the vaccine's safety, what can you tell her?
-
Rate control vs rhythm control for atrial fibrillation continues to be debated with most of the evidence falling on the side of rate control in recent years, primarily because of adverse effects from anti-arrhythmics. A new drug may change that however.
-
The FDA has issued a public health advisory regarding the risk of progressive multifocal leukoencephalopathy (PML) associated with use of efalizumab (Raptiva®) for the treatment of psoriasis.
-
